Aberrant expression of microRNAs in bladder cancer

Nature Reviews Urology

Volumn 10, Issue 7, 2013, Pages 396-404

  Yoshino, Hirofumi ^a   Seki, Naohiko ^b   Itesako, Toshihiko ^a   Chiyomaru, Takeshi ^a   Nakagawa, Masayuki ^a   Enokida, Hideki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 100; MICRORNA 101; MICRORNA 125B; MICRORNA 126; MICRORNA 129; MICRORNA 133A; MICRORNA 133B; MICRORNA 141; MICRORNA 143; MICRORNA 145; MICRORNA 17 5P; MICRORNA 182; MICRORNA 183; MICRORNA 195; MICRORNA 200C; MICRORNA 20A; MICRORNA 221; MICRORNA 222; MICRORNA 224; MICRORNA 26A; MICRORNA 29A; MICRORNA 29C; MICRORNA 34A; MICRORNA 452; MICRORNA 93; MICRORNA 96; RNA INDUCED SILENCING COMPLEX; RNA POLYMERASE II; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; APOPTOSIS; BIOGENESIS; BLADDER CANCER; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELL INVASION; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DISEASE COURSE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; TUMOR RECURRENCE; UPREGULATION;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84880253813     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2013.113     Document Type: Review

References (102)

1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108 (2005 (Pubitemid 40372904)
2. Ferlay, J., Parkin, D. M. & Steliarova-Foucher, E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 46, 765-781 (2010
3. Zuiverloon, T. C. et al. Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: A systematic review. Eur. Urol. 61, 1245-1256 (2012
4. Luke, C., Tracey, E., Stapleton, A. & Roder, D. Exploring contrary trends in bladder cancer incidence, mortality and survival: Implications for research and cancer control. Intern. Med. J. 40, 357-362 (2010
5. Meeks, J. J. et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur. Urol. 62, 523-533 (2012
6. Shirodkar, S. P. & Lokeshwar, V. B. Potential new urinary markers in the early detection of bladder cancer. Curr. Opin. Urol. 19, 488-493 (2009
7. Nelson, K. M. & Weiss, G. J. MicroRNAs and cancer: Past, present, and potential future. Mol. Cancer Ther. 7, 3655-3660 (2008
8. Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet. 9, 102-114 (2008
9. Esquela-Kerscher, A. & Slack, F. J. Oncomirs - MicroRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269 (2006
10. Catto, J. W. et al. MicroRNA in prostate, bladder, and kidney cancer: A systematic review. Eur. Urol. 59, 671-681 (2011
11. Youssef, Y. M. et al. Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur. Urol. 59, 721-730 (2011
12. Carthew, R. W. & Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655 (2009
13. Bartel, D. P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004
14. Rodriguez, A. et al. Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902-1910 (2004 (Pubitemid 39386503)
15. Lee, Y. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060 (2004 (Pubitemid 39472426)
16. Cai, X., Hagedorn, C. H. & Cullen, B. R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10, 1957-1066 (2004
17. O'Kelly, F. et al. MicroRNAs as putative mediators of treatment response in prostate cancer. Nat. Rev. Urol. 9, 397-407 (2012
18. Gregory, R. I. & Shiekhattar, R. MicroRNA biogenesis and cancer. Cancer Res. 65, 3509-3512 (2005 (Pubitemid 40616320)
19. He, L. & Hannon, G. J. MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531 (2004 (Pubitemid 38868508)
20. Rand, T. A., Petersen, S., Du, F. & Wang, X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123, 621-629 (2005 (Pubitemid 41608465)
21. Orom, U. A., Nielsen, F. C. & Lund, A. H. MicroRNA 10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell. 30, 460-471 (2008 (Pubitemid 351672378)
22. Tay, Y., Zhang, J., Thomson, A. M., Lim, B. & Rigoutsos, I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124-1128 (2008
23. Yang, H. et al. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res. 68, 2530-2537 (2008 (Pubitemid 351521830)
24. Teo, M. T. et al. The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis 33, 581-586 (2012
25. Calin, G. A. et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99, 15524-15529 (2002 (Pubitemid 35403967)
26. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (2006 (Pubitemid 44629897)
27. Davis, B. N. & Hata, A. microRNA in cancer: The involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer 1, 1100-1114 (2010
28. Mavrakis, K. J., Leslie, C. S. & Wendel, H. G. Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs. Cell Cycle 10, 2845-2849 (2011
29. Inui, M., Martello, G. & Piccolo, S. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11, 252-263 (2010
30. Ory, B. & Ellisen, L. W. A microRNA-dependent circuit controlling p63/p73 homeostasis: P53 family cross-talk meets therapeutic opportunity. Oncotarget 2, 259-264 (2011
31. Noonan, E. J., Place, R. F., Basak, S., Pookot, D. & Li, L. C. miR 449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1, 349-358 (2010
32. Erkan, E. P., Breakefield, X. O. & Saydam, O. miRNA signature of schwannomas: Possible role(s) of "tumor suppressor" miRNAs in benign tumors. Oncotarget 2, 265-270 (2011
33. Nair, V. S., Maeda, L. S. & Ioannidis, J. P. Clinical outcome prediction by microRNAs in human cancer: A systematic review. J. Natl Cancer Inst. 104, 528-540 (2012
34. University of Manchester miRBase [online], http://microrna.sanger.ac.uk (2013
35. Chen, Y. H. et al. Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing. Urol. Oncol. 31, 219-227 (2013
36. Han, Y. et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS ONE 6, e18286 (2011
37. Yoshino, H. et al. The tumour-suppressive function of miR 1 and miR 133a targeting TAGLN2 in bladder cancer. Br. J. Cancer 104, 808-818 (2011
38. Catto, J. W. et al. Distinct microRNA alterations characterize high-and low-grade bladder cancer. Cancer Res. 69, 8472-8481 (2009
39. Dyrskjøt, L. et al. Genomic profiling of microRNAs in bladder cancer: LMiR 129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 69, 4851-4860 (2009
40. Wang, G. et al. Up-regulation of microRNA in bladder tumor tissue is not common. Int. Urol. Nephrol. 42, 95-102 (2010
41. Ichimi, T. et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 125, 345-352 (2009
42. Hanke, M. et al. A robust methodology to study urine microRNA as tumor marker: LMicroRNA 126 and microRNA 182 are related to urinary bladder cancer. Urol. Oncol. 28, 655-661 (2010
43. Friedman, J. M. et al. The putative tumor suppressor microRNA 101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res. 69, 2623-2629 (2009
44. Lin, T. et al. MicroRNA 143 as a tumor suppressor for bladder cancer. J. Urol. 181, 1372-1380 (2009
45. Gottardo, F. et al. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 25, 387-392 (2007 (Pubitemid 47362758)
46. Noguchi, S. et al. MicroRNA 143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett. 307, 211-220 (2011
47. Villadsen, S. B. et al. The miR 143/ 145 cluster regulates plasminogen activator inhibitor 1 in bladder cancer. Br. J. Cancer 106, 366-374 (2012
48. Ostenfeld, M. S. et al. miR 145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 29, 1073-1084 (2010
49. Huang, L. et al. MicroRNA 125b suppresses the development of bladder cancer by targeting E2F3. Int. J. Cancer 128, 1758-1769 (2011
50. Kawakami, K. et al. The functional significance of miR 1 and miR 133a in renal cell carcinoma. Eur. J. Cancer 48, 827-836 (2012
51. Nohata, N. et al. Identification of novel molecular targets regulated by tumor suppressive miR 1/miR 133a in maxillary sinus squamous cell carcinoma. Int. J. Oncol. 39, 1099-1107 (2011
52. Kojima, S. et al. Tumour suppressors miR 1 and miR 133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br. J. Cancer 106, 405-413 (2012
53. Nohata, N., Hanazawa, T., Enokida, H. & Seki, N. microRNA 1/133a and microRNA 206/133b clusters: Dysregulation and functional roles in human cancers. Oncotarget 3, 9-21 (2012
54. Lin, Y. et al. Cyclin-dependent kinase 4 is a novel target in microRNA 195 mediated cell cycle arrest in bladder cancer cells. FEBS Lett. 586, 442-447 (2012
55. Xu, C. et al. miRNA 100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR. Mol. Cancer Ther. 12, 207-219 (2013
56. Zhou, Y. et al. MicroRNA 133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer. Scand. J. Urol. http://dx.doi.org/10.3109/ 00365599.2012.748821
57. Mihelich, B. L. et al. miR 183 96 182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J. Biol. Chem. 286, 44503-44511 (2011
58. Zhu, W. et al. Overexpression of members of the microRNA 183 family is a risk factor for lung cancer: A case control study. BMC Cancer 11, 393 (2011
59. Myatt, S. S. et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res. 70, 367-377 (2010
60. Liu, Y. et al. Synthetic miRNA-mowers targeting miR 183 96 182 cluster or miR 210 inhibit growth and migration and induce apoptosis in bladder cancer cells. PLoS ONE 7, e52280 (2012
61. He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005 (Pubitemid 40839734)
62. Calin, G. A. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101, 2999-3004 (2004 (Pubitemid 38327724)
63. Yamada, Y. et al. MiR 96 and miR 183 detection in urine serve as potential tumor markers of urothelial carcinoma: Correlation with stage and grade, and comparison with urinary cytology. Cancer Sci. 102, 522-529 (2011
64. Puerta-Gil, P. et al. miR 143, miR 222, and miR 452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am. J. Pathol. 180, 1808-1815 (2012
65. Wiklund, E. D. et al. Coordinated epigenetic repression of the miR 200 family and miR 205 in invasive bladder cancer. Int. J. Cancer 128, 1327-1334 (2011
66. Veerla, S. et al. MiRNA expression in urothelial carcinomas: Important roles of miR 10a, miR 222, miR 125b, miR 7 and miR 452 for tumor stage and metastasis, and frequent homozygous losses of miR 31. Int. J. Cancer 124, 2236-2242 (2009
67. Yoshino, H. et al. Tumor suppressive microRNA 1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochem. Biophys. Res. Commun. 417, 588-593 (2012
68. Chiyomaru, T. et al. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol. Oncol. 30, 434-443 (2012
69. Cao, Y. et al. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumour Biol. 32, 179-188 (2011
70. Lodygin, D. et al. Inactivation of miR 34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600 (2008
71. Chiyomaru, T. et al. miR 145 and miR 133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer 102, 883-891 (2010
72. Fei, X. et al. MicroRNA 195 5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett. 586, 392-397 (2012
73. Adam, L. et al. miR 200 expression regulates epithelial to mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin. Cancer Res. 15, 5060-5072 (2009
74. Kenney, P. A. et al. Novel ZEB1 expression in bladder tumorigenesis. BJU Int. 107, 656-663 (2011
75. Bo, J. et al. microRNA 203 suppresses bladder cancer development by repressing bcl w expression. FEBS J. 278, 786-792 (2011
76. Saini, S. et al. Curcumin modulates microRNA 203 mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. (Phila.) 4, 1698-1709 (2011
77. Chen, H. et al. MicroRNA 449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett. 320, 40-47 (2012
78. Ueno, K. et al. Tumor suppressor microRNA 493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol. Cancer Ther. 11, 244-253 (2012
79. Hirata, H. et al. MicroRNA 1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 33, 41-48 (2012
80. Lu, Q. et al. MicroRNA 221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL. Urol. Oncol. 28, 635-641 (2010
81. Gómez-Román, J. J. et al. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth. Clin. Cancer Res. 11, 459-465 (2005 (Pubitemid 40116867)
82. Huber, M. A., Kraut, N. & Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548-558 (2005 (Pubitemid 41267170)
83. Xu, J., Lamouille, S. & Derynck, R. TGF beta induced epithelial to mesenchymal transition. Cell Res. 19, 156-172 (2009
84. Zaman, M. S. et al. The functional significance of microRNA 145 in prostate cancer. Br. J. Cancer 103, 256-264 (2010
85. Schepeler, T. et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 68, 6416-6424 (2008
86. Iorio, M. V. et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 67, 8699-8707 (2007 (Pubitemid 47437445)
87. Kano, M. et al. miR 145, miR 133a and miR 133b: Tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 127, 2804-2814 (2010
88. Akao, Y., Nakagawa, Y., Kitade, Y., Kinoshita, T. & Naoe, T. Downregulation of microRNAs 143 and 145 in B cell malignancies. Cancer Sci. 98, 1914-1920 (2007
89. Wang, L. et al. Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res. 69, 9490-9497 (2009
90. Sachdeva, M. & Mo, Y. Y. miR 145 mediated suppression of cell growth, invasion and metastasis. Am. J. Transl. Res. 2, 170-180 (2010
91. Altuvia, Y. et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33, 2697-2706 (2005 (Pubitemid 41511287)
92. Baskerville, S. & Bartel, D. P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241-247 (2005 (Pubitemid 40270816)
93. Aqeilan, R. I., Calin, G. A. & Croce, C. M. miR 15a and miR 16 1 in cancer: Discovery, function and future perspectives. Cell Death Differ. 17, 215-220 (2010
94. Olive, V., Jiang, I. & He, L. mir 17 92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 42, 1348-1354 (2010
95. Iio, A., Nakagawa, Y., Hirata, I., Naoe, T. & Akao, Y. Identification of noncoding RNAs embracing microRNA 143/145 cluster. Mol. Cancer 9, 136 (2010
96. Wang, Y. & Lee, C. G. MicroRNA and cancer-focus on apoptosis. J. Cell. Mol. Med. 13, 12-23 (2009
97. Dostalova Merkerova, M. et al. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome. Eur. J. Hum. Genet. 19, 313-319 (2011
98. Suzuki, H. I. et al. Modulation of microRNA processing by p53. Nature 460, 529-533 (2009
99. Sachdeva, M. et al. p53 represses c Myc through induction of the tumor suppressor miR 145. Proc. Natl Acad. Sci. USA 106, 3207-3212 (2009
100. Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6, 635-645 (2005 (Pubitemid 41081267)
101. Levy, N., Yonish-Rouach, E., Oren, M. & Kimchi, A. Complementation by wild-type p53 of interleukin 6 effects on M1 cells: Induction of cell cycle exit and cooperativity with c myc suppression. Mol. Cell Biol. 13, 7942-7952 (1993 (Pubitemid 23354319)
102. Boominathan, L. The guardians of the genome (p53, TA p73, and TA p63) are regulators of tumor suppressor miRNAs network. Cancer Metastasis Rev. 29, 613-639 (2010